PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 193 filers reported holding PDL BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $142,000 | +19.3% | 51,900 | +45.8% | 0.01% | -20.0% |
| Q3 2016 | $119,000 | -78.9% | 35,600 | -80.2% | 0.01% | -81.1% |
| Q2 2016 | $564,000 | +1.4% | 179,700 | +126.9% | 0.05% | -32.1% |
| Q1 2015 | $556,000 | -55.7% | 79,200 | -51.4% | 0.08% | -63.0% |
| Q4 2014 | $1,256,000 | -61.5% | 163,000 | -62.7% | 0.21% | -56.9% |
| Q3 2014 | $3,262,000 | -22.7% | 436,800 | 0.0% | 0.49% | -21.9% |
| Q2 2014 | $4,219,000 | +6.8% | 436,800 | -8.4% | 0.63% | +2.0% |
| Q1 2014 | $3,952,000 | -12.3% | 476,800 | -10.8% | 0.62% | -21.2% |
| Q4 2013 | $4,504,000 | +226.6% | 534,400 | +208.7% | 0.78% | +147.6% |
| Q3 2013 | $1,379,000 | – | 173,100 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |